Mode
Text Size
Log in / Sign up

Neuroendoscopic resection of a collision tumor involving null-cell adenoma and Adamantinomatous craniopharyngiomaRare collision tumor found in patient with pituitary symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the risk of occult collision tumors in pituitary lesions and the necessity of immunohistochemistry for diagnosis.

This case report describes the surgical management of a 64-year-old female presenting with fatigue, anorexia, palpitations, dizziness, and exertional dyspnea. The patient was diagnosed with a collision tumor consisting of a null-cell adenoma and an Adamantinomatous craniopharyngioma.

A primary challenge noted by the authors was that imaging and surgical texture failed to differentiate the components of the pathology. This led to a blind resection of the collision pathology due to a lack of discernible boundaries and indistinguishability on preoperative imaging. The patient experienced a cavernous sinus hemorrhage of 800 mL during the procedure.

The report highlights the diagnostic pitfall of occult collision tumors in the pituitary region. Because these tumors can appear as single entities on imaging, the authors suggest that comprehensive immunohistochemistry is essential for accurate diagnosis. This case serves as a clinical reminder regarding the limitations of preoperative imaging in identifying complex tumor overlaps.

How this fits prior evidence

This case report addresses a gap in the identification of complex pituitary pathologies. While previous evidence notes that automated MRI segmentation for pituitary adenomas shows variable accuracy, this case highlights how even standard imaging may fail to differentiate between distinct components of a collision tumor. It does not relate to findings regarding intracranial aneurysm prevalence or menopausal impacts on inflammatory conditions.

Imagine feeling exhausted, dizzy, and short of breath, only to find out your body is fighting two different types of tumors at once. This is what happened to a 64-year-old woman who presented with fatigue and palpitations. Doctors eventually discovered she had a collision tumor: a rare occurrence where two different types of tumors grow in the same spot.

The doctors performed a surgery called a neuroendoscopic transsphenoidal resection. Because the two tumors were so similar on imaging, they could not be told apart before the operation. This made it impossible for surgeons to see where one ended and the other began. During the procedure, the patient suffered a serious complication involving a large amount of blood in a nearby area called the cavernous sinus.

While the surgery was successful, this case highlights how difficult it can be to identify these hidden tumors before an operation. Because imaging could not distinguish between the two types of tumors, doctors had to rely on special testing after surgery to confirm what they were seeing. This case serves as a reminder that some conditions are much more complex than what a scan might show.

What this means for you:
A rare dual tumor was found in one patient because it was impossible to see the two types on scans.

Common questions

What is a collision tumor?

A collision tumor happens when two different types of tumors grow in the same location. In this specific case, the patient had both a Null-cell adenoma and an Adamantinomatous craniopharyngioma. These were so similar that doctors could not tell them apart on scans before surgery.

What complications occurred during the surgery?

During the procedure, the patient experienced a serious complication known as a cavernous sinus hemorrhage involving 800 mL of blood. This is a significant amount of bleeding in a specific area near the brain.

Why was it hard for doctors to see the two tumors separately?

The imaging and surgical textures failed to differentiate between the components of the tumor. Because they looked identical on scans, surgeons could not find a clear boundary between the two different types of growths before they began the operation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Collision tumors harbor two distinct histological features at the same site, and sellar collision tumors of pituitary adenoma (PA) and craniopharyngioma (CP) are extremely rare. This report presents a 64-year-old female with fatigue, anorexia, palpitations, dizziness, and exertional dyspnea. Examinations confirmed pan-hypopituitarism and life-threatening electrolyte disturbances. Preoperative MRI showed a homogeneous lesion indistinguishable from a standard macroadenoma. She underwent neuroendoscopic transsphenoidal resection. Intraoperatively, the tumor exhibited a fibrous, tough consistency with no discernible boundary between components, resulting in a “blind” resection of the collision pathology. Significant cavernous sinus hemorrhage (800 mL) occurred due to severe adhesion. Postoperatively, hormone replacement therapy was administered, with stable recovery and discharge on day 18. Pathology confirmed a collision of Null-cell adenoma and Adamantinomatous CP. This case highlights the diagnostic pitfall of “occult” collision tumors where imaging and surgical texture fail to differentiate components, necessitating comprehensive immunohistochemistry. Few similar cases have been reported, mostly involving non-functional PA and adamantinomatous CP with diverse pathogenesis hypotheses. This case supplements critical clinical data on diagnosis, surgical management, and prognosis of this rare sellar tumor, highlighting therapeutic considerations for neurosurgery clinicians.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.